Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Submitted by
admin
on August 4, 2012 - 12:49pm
Source:
Digital Journal
News Tags:
Takeda
Actos
diabetes
type 2 diabetes
Headline:
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Do Not Allow Advertisers to Use My Personal information
